This 75-minute on-demand session from the ASAM 56th Annual Conference addresses barriers to treatment engagement for pregnant individuals with opioid use disorder, strategies for developing SMART goals to improve retention, and the role of peer recovery specialists in supporting patient retention.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses emerging substances of misuse and their impact on pregnancy, with guidance on harm reduction, clinical care, and counseling in the context of evolving cannabis and CBD use.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the extrapolation and application of the ASAM/AAAP guidelines for management of Stimulant Use Disorders (StUD) to perinatal populations and highlights key physiological considerations and implications for maternal and neonatal wellbeing that impact treatment choices.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the latest scientific data, clinical and advocacy issues, and diverse viewpoints on cannabis use during pregnancy and breastfeeding, including its adverse effects and related policy debates.

This one-hour, on-demand, journal article-based activity examines the risks associated with pregnancy and elective termination among females receiving treatment for substance use disorder (SUD) compared to those not in treatment.

This one-hour, on-demand, journal article-based activity examines findings from 22 published case reports on the effects of inhalant use during pregnancy. It explores the impact on maternal health, fetal development, neonatal outcomes, and early childhood.

This one-hour, on-demand, journal article-based activity presents original research on the prescribing of medications for alcohol use disorder (MAUD) among birthing people with an alcohol-related diagnosis. Although safety and effectiveness of medications for alcohol use disorder (MAUD) are generally well established for adults, the literature on its use in pregnancy is limited. To better understand the benefit and risks of medications for AUD in pregnancy, this study offers an analysis of insurance claim data to estimate the prevalence of birthing people currently receiving prescriptions for medications for alcohol use disorder.

This two-hour online course equips healthcare professionals with the essential knowledge, skills, and tools to effectively identify and treat women with substance use disorders (SUDs).

This 8-hour, online course provides the education that is essential for providers to identify, assess, diagnose, and manage pregnant and postpartum patients with opioid use disorder (OUD).